Article info

Download PDFPDF
The Use of Endometrial Cancer Patient–Derived Organoid Culture for Drug Sensitivity Testing Is Feasible

Authors

  1. Address correspondence and reprint requests to Eugenia Girda, MD, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, UC Davis Medical Center, 4860 Y St, Suite 2500, Sacramento, CA 95817. E-mail: egirda@ucdavis.edu.

Citation

Girda E, Huang EC, Leiserowitz GS, et al
The Use of Endometrial Cancer Patient–Derived Organoid Culture for Drug Sensitivity Testing Is Feasible

Publication history

  • Received February 10, 2017
  • First published October 1, 2017.
Online issue publication 
October 01, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.